About Michael Little
Michael Little is a director at Biometry.
Michael Little first appears on SEC filings in 2024.
Experience
This experience comes from Michael Little's profile and from SEC filings. For roles taken from filings, the years are when the filings name Michael Little in the role, so the role may have started earlier or lasted longer.
MT
Maternica Therapeutics Current
Chief Executive Officer
2022 – Present
Biometry Inc. Current
Board of Directors
2014 – Present · Lowell, MA
Develops breath monitoring technology for people with asthma and COPD.
FL
Futura Partners LLC
President
2014 – 2022
QI
QIAGEN
Global Head Development MDx Business Area
2018 – 2019
AB
Abreos Biosciences
Chief Operating Officer
2017
NA
Natera
Senior Vice President
2015 – 2017
PC
Popper and Company
Senior Advisor
2014 – 2015
NP
Novartis Pharmaceuticals
Global Head Diagnostics Development
2009 – 2014
ND
Novartis Diagnostics
VP R&D, Clinical, Regulatory, and Scientific Affairs
2007 – 2009
AD
Adlyfe
Chief Operating Officer
2006 – 2007
BD
BD Diagnostics
WW Business Leader Molecular
2000 – 2006
Key Colleagues at Startups
The people Michael Little works with at each company, as listed on that company's latest Form D.
Biometry Inc. · Form D/A, Jul 23, 2026
Joel Myerson
Director
HK
Harold Kisner
Director
Bryan Nolan
Founder, CEO, Chairman
JG
Joseph Gentile
Director